Factors such as growth in companion animal adoption, increasing number of veterinary practitioners and their rising income levels in developed economies, growing prevalence of animal disease causing pain and inflammation, and the rising adoption of pet insurance with growing animal health expenditure are expected to drive the growth of the market.

The Animal Pain Management Market is projected to reach USD 1.66 Billion by 2023 from USD 1.13 Billion in 2018, at a CAGR of 8.0% during the forecast period.

Years considered for this report:

2017 – Base Year
2018 – Estimated Year
2023 – Projected Year

By drug type, disease-modifying osteoarthritis agents are expected to grow at the highest CAGR during 2018-2023

Based on drug type, the Veterinary Pain Management Market is segmented into non-steroidal anti-inflammatory drugs (NSAIDs), opioids, alpha-2 agonists, local anesthetics, disease-modifying osteoarthritis agents (DMOAAs), and other drugs. The DMOAAs segment is expected to grow at the highest CAGR during the forecast period. The high growth rate of this segment can be attributed to the high prevalence of arthritis in animals. However, NSAIDs are expected to hold the largest share in the market due to their wide range of applications areas and low cost.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=96167677

By application, joint pain accounted for the largest market share in 2017

Based on application, the Animal Pain Management Market has been segmented into joint pain, postoperative pain, cancer, and other applications. Other applications include traumatic pain, abdominal pain, neuropathic pain, dermatological pain, and mastitis. In 2017, joint pain held the largest share of the veterinary pain management market. The dominant share of this application segment has been attributed to the growing pet population, rising prevalence of osteoarthritis and musculoskeletal disorders in animals, and the increasing population of obese and overweight pets.

Veterinary hospitals & clinics are expected to be the largest distribution channel for veterinary pain management products in 2017.

Based on distribution channels, the veterinary pain management market is segmented into hospitals & clinics and pharmacies. In 2017, veterinary hospitals & clinics accounted for a larger market share than pharmacies primarily due to factors such as the increasing number of veterinary clinics and hospitals, growing ownership of companion animals, and increasing veterinary expenditure.

North America dominated the Animal Pain Management Market, followed by Europe. In North America, the US is expected to hold the largest share of the global market due to the vast pet population in the region, increasing animal healthcare expenditure, large number of hospitals & clinics, growing pool of veterinarians, and high prevalence of diseases causing pain as well as the growing number of research and funding activities in the field of veterinary pain management.

The Asia Pacific veterinary pain management market is estimated to grow at the highest CAGR during the forecast period and countries such as Japan, China, and India are expected to provide significant growth opportunities for market players. These countries have a large livestock population, as well a growing trend of pet ownership.

The prominent players in the market are Zoetis.(US), Merck Animal Health (US), Elanco (US), Chanelle (Ireland), Boehringer Ingelheim (Germany), Vetoquinol (France), Bayer Germany), Norbrook (Ireland), Ceva Santé Animale (France), K-Laser (US), Assisi (US), and Dechra Pharmaceuticals (UK). New product launches and acquisitions were the major strategies adopted by these payers to maintain their positions in the global market.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=96167677

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]